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Background: The purpose was to compare the changes in claudication pain, ambulatory function, daily physical activity,
peripheral circulation, and health-related quality of life following a program of exercise rehabilitation in smoking and
nonsmoking patients with peripheral arterial disease (PAD) limited by intermittent claudication.
Methods and results: Thirty-nine smokers (63  4 pack-year smoking history; mean  SE) and 46 nonsmokers (former
smokers who had a 51 7 pack-year smoking history who quit 14 2 years prior to investigation) completed the study.
The 6-month exercise rehabilitation program consisted of intermittent treadmill walking to near maximal claudication
pain 3 days per week, with progressive increases in walking duration and intensity during the program. Measurements
were obtained on each patient before and after rehabilitation. Following exercise rehabilitation the smokers and
nonsmokers had similar improvements in these measures, as initial claudication distance increased by 119% in the smokers
(P < .001) and by 97% in the nonsmokers (P < .001), and absolute claudication distance increased by 82% (P < .001)
and 59% (P < .001) in the smokers and nonsmokers, respectively. Furthermore, exercise rehabilitation improved (P <
.05) ambulatory function, daily physical activity, peripheral circulation, and health-related quality of life in the smokers
and nonsmokers.
Conclusion: Exercise rehabilitation is an effective therapy to improve functional independence in both smoking and
nonsmoking patients with PAD limited by intermittent claudication. Therefore, smokers with intermittent claudication
are prime candidates for exercise rehabilitation because their relatively low baseline physical function does not impair
their ability to regain lost functional independence to levels similar to nonsmoking patients with PAD. (J Vasc Surg
2004;39:531-8.)
Peripheral arterial disease (PAD) is a leading cause of
morbidity as a result of ambulatory dysfunction associated
with intermittent claudication.1 Intermittent claudication
afflicts 5% of the US population older than 55 years,2
thereby limiting daily physical activities3 and negatively
affecting quality of life4 in many older adults. A primary
therapeutic goal for patients with PAD with intermittent
claudication is to regain lost physical function through
exercise rehabilitation.5 Medically supervised exercise pro-
grams have been studied extensively over the past 35 years
and are effective for the clinical management of intermit-
tent claudication.6 Specifically, exercise rehabilitation im-
proves initial claudication distance (ICD), absolute claudi-
cation distance (ACD), measured and perceived
ambulatory function, physical activity level, quality of life,
and calf blood flow in patients with PAD limited by inter-
mittent claudication.6-14
Cigarette smoking is commonly reported in patients
with PAD,15 having both long-term and short-term affects
on arterial blood flow in the lower extremities. For exam-
ple, cigarette smoking is a primary risk factor for develop-
ment and progression of PAD16 and causes lingering im-
pairments in peripheral blood flow and oxygen delivery to
the lower-extremity musculature following acute exposure
to smoking.17,18 It is, therefore, not surprising that patients
with PAD who currently smoke have more severe claudica-
tion, as well as lower exercise capacity, peripheral circula-
tion, and physical activity levels than their nonsmoking
counterparts.19,20 Consequently, patients with PAD who
smoke are on the lower end of the physical function spec-
trum and may be prime candidates to regain lost functional
independence through a program of exercise rehabilitation.
The purpose of this study was to compare the changes
in claudication pain, ambulatory function, physical activity
level, peripheral circulation, and health-related quality of
life following a program of exercise rehabilitation in current
smoking and nonsmoking patients with PAD limited by
intermittent claudication.
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METHODS
Patients
Screening. A total of 106 patients with PAD limited
by intermittent claudication were enrolled into an interven-
tion development study and several pilot studies as part of
the University of Maryland Claude D. Pepper Older Amer-
icans Independence Center. The patients were recruited
from the Vascular Clinic at the Baltimore location of the
Maryland Veterans Affairs Health Care System
(MVAHCS), and from newspaper and radio advertise-
ments in Baltimore. All patients underwent a physical ex-
amination during the first baseline visit and were classified
as having Fontaine stage II PAD21 defined by the following
inclusion criteria: (1) a positive Rose questionnaire for
intermittent claudication,22 (2) intermittent claudication
elicited during a screening treadmill test, and (3) an ankle/
brachial index (ABI) at rest 0.97.23 Patients were ex-
cluded from this study for the following conditions: (1)
absence of PAD; (2) asymptomatic PAD (Fontaine stage I);
(3) rest pain PAD (Fontaine stage III); (4) exercise toler-
ance limited by factors other than claudication (eg, coro-
nary artery disease, dyspnea, poorly controlled blood pres-
sure); and (5) active cancer, renal disease, or liver disease.
All patients lived independently at home. The Institutional
Review Boards at the University of Maryland and the
MVAHCS at Baltimore approved the procedures used in
this study. Written informed consent was obtained from
each subject prior to investigation.
Smoking status. A smoking history was obtained, and
patients were classified as either current smokers (n  50)
or nonsmokers (n  56), defined as not having smoked
over the preceding year. All of those patients included in
the nonsmoking group reported a previous history of
smoking. The average number of cigarette packs smoked
per day and the total number of years of smoking were
recorded to determine the pack-year history of the patients.
Additionally, the number of years that the nonsmokers had
quit smoking was recorded. Smoking status was confirmed
at baseline and throughout the study by having the patients
breathe into a 2000 Series Ecolyzer carbon monoxide
analyzer (National Draeger, Inc, Pittsburgh, Pa) to assess
the concentration of carbon monoxide in the expired air.18
Exercise rehabilitation
The exercise rehabilitation program consisted of 6
months of supervised, intermittent treadmill walking to
near maximal claudication pain three days per week as
previously described.7-9 There were no complications dur-
ing the exercise training sessions. Ten patients from the
nonsmoking group and 11 patients from the smoking
group withdrew soon after beginning the exercise rehabil-
itation program. The remaining 46 nonsmokers and 39
smokers completed the exercise intervention and posttreat-
ment measures and, therefore, comprise the sample for the
final analyses. Both groups were assessed on the following
measurements before and after the exercise rehabilitation
program.
Measurements
Medical history. Demographic information, cardio-
vascular risk factors, comorbidites, and self-reported clau-
dication history were obtained during a medical history
interview to begin the evaluation.
Claudication distances and peak oxygen up-
take. Patients performed a progressive, graded treadmill
protocol (2 mph, 0% grade with 2% increase every 2 min-
utes) until maximal claudication pain as previously de-
scribed.24 The ICD, ACD, time to relief of claudication
pain after the test, and peak oxygen uptake were measured.
Because handrail support impairs the reliability of claudica-
tion pain measurements,25 patients were only allowed to
touch the treadmill handrail for brief moments during the
test to maintain balance.
Walking economy. Oxygen uptake was measured
during a constant, submaximal work rate at a treadmill
speed of 2 mph and a grade of 0% until maximal claudica-
tion pain, or for a maximum of 20 minutes.26 Because the
duration of submaximal exercise affects oxygen uptake, we
compared the oxygen uptake of each patient at the same
time point before and after the study.26 Consequently,
walking economy was measured as the oxygen uptake dur-
ing the final minute of walking at baseline and at the same
time point during the posttest.
Six-minute walk test: Patients performed an over
ground, 6-minute walk test supervised by trained exercise
technicians as previously described.27 The pain-free and
total distance walked during the test were recorded.
Walking impairment questionnaire (WIQ). Self-re-
ported ambulatory ability was assessed using a validated
questionnaire for patients with PAD that assesses ability to
walk at various speeds and distances and to climb stairs.28
Daily physical activity. Physical activity level was
monitored over 2 consecutive weekdays by a Caltrac accel-
erometer (Muscle Dynamics, Torrance, Calif) attached to
the belt of each subject as previously described.29 The
accelerometer assessed daily physical movements by con-
verting vertical accelerations of the body into caloric expen-
diture during the 48-hour monitoring period.30,31
ABI and ischemic window. As previously described,
ABI was obtained from the more severely diseased lower
extremity by the Doppler ultrasound technique before and
1, 3, 5, and 7 minutes after the progressive, graded tread-
mill test used to assess claudication distances and peak
oxygen uptake.24 The reduction in ankle systolic blood
pressure following the treadmill test from the resting value
was quantified by calculating the area under the curve,
referred to as the ischemic window.32 To assess the change
in the ischemic window following exercise rehabilitation,
patients performed an additional progressive, graded
treadmill test at follow-up but were stopped when they
achieved the same walking distance as was measured at
baseline. This technique permitted comparison of the
change in the ischemic window for a given walking distance
before and after exercise rehabilitation, as described by
Carter et al.33
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Calf blood flow. Calf blood flow was obtained under
resting, reactive hyperemic, and maximal hyperemic condi-
tions in the more severely diseased leg using venous occlu-
sion mercury strain-gauge plethysmography as previously
described.10,34-37
Quality of life. Health-related quality of life was as-
sessed with the Medical Outcomes Study Short-Form 36
(MOS SF-36) General Health Survey.38 The MOS SF-36 is
a reliable and valid generic instrument which includes
multi-item scales that measure the following eight health
domains: physical function, role limitations because of
physical problems, general health, bodily pain, social func-
tion, role limitations because of emotional problems, men-
tal health, and vitality. For each subscale, item scores were
recorded, summed, and standardized into a scale from 0 to
100, with better health states resulting in higher scores.
Statistical analyses
Comparing current smoking and nonsmoking groups
of patients with intermittent claudication was an a priori
specific aim of the Intervention Development Study of the
University of Maryland Pepper Center. Unpaired t tests
and chi square tests were used to assess whether differences
in baseline clinical characteristics existed between the
smokers and nonsmokers. A series of one-factor (group;
smokers versus nonsmokers) analyses of covariance
(ANCOVA) were used to compare the changes in the
functional, physiologic, and quality of life variables between
the smoking and nonsmoking patients having both
pretest and posttest data points. The dependent variable in
each of the ANCOVAs was the within-person difference
(posttest minus pretest) in the variable being analyzed. The
initial value of the dependent variable was included as
an independent covariate to adjust for the difference in its
initial value. On the basis of previous studies,7-9 the sample
sizes of the smoking and nonsmoking groups yielded
statistical power estimates of greater than 90% to
detect exercise-mediated changes in ICD and ACD
and greater than 70% to detect changes in most of the other
measurements. Pearson product-moment correlation coef-
ficients (r) were calculated to determine the association
between the change in variables following exercise rehabil-
itation. Statistical significance was set at P .05. Measure-
ments are presented as means  standard errors.
RESULTS
Similar baseline clinical characteristics were found be-
tween the two groups (Table I), except that the smoking
group had smoked cigarettes for 11 additional years (P 
.05) and had a higher pack-year history (P  .05) than the
nonsmoking patients who, on average, had quit smoking
14 years prior to investigation. Smoking did not affect the
adherence to the exercise rehabilitation program, as the
average attendance was similar (P  .05) between the
smoking group (73%  4%), and the nonsmoking group
(77%  4%). Furthermore, the smoking group had no
change (P  .05) in cigarette consumption before (1.4 
0.1 packs/day) and after (1.3  0.1 packs/day) the exer-
cise rehabilitation program.
The treadmill measures shown in Table II indicate that
the smoking group had significantly lower (P  .05) ICD,
ACD, and peak oxygen uptake than the nonsmoking group
at baseline, whereas the time to relief of claudication pain
and walking economy were similar (P  .05). Both groups
demonstrated a significant (P  .05) and similar improve-
ment in ICD, ACD, peak oxygen uptake, and walking
economy following exercise rehabilitation. Neither group
had a significant (P  .05) change in the time to relief of
claudication pain following the exercise program.
The ambulatory and physical activity measures shown
in Table III indicate that the smoking group had signifi-
cantly lower (P  .05) baseline values on all variables
compared with the nonsmoking group. Both groups had a
significant (P  .05) and similar improvement in the pain-
free and total walking distances during the 6-minute walk
test, WIQ distance score, and daily physical activity follow-
ing exercise rehabilitation. However, only the smokers had
a significant (P  .05) improvement in the WIQ speed
score and the WIQ stair climbing score.
The peripheral hemodynamic measurements displayed
in Table IV indicate that the smoking group had signifi-
cantly lower (P  .05) calf blood flow under resting,
reactive hyperemic, and maximal hyperemic conditions
than the nonsmoking group at baseline, whereas ABI and
ischemic window were similar (P  .05). Both groups had
a significant (P  .05) and similar improvement in the calf
blood flow measures and in the ischemic window following
exercise rehabilitation. However, the calf blood flow mea-
sures in the smoking group remained lower (P .05) than
the nonsmoking group during follow-up. Neither group
had a significant (P  .05) change in ABI following the
exercise program. As a result of similar vascular changes
Table I. Baseline clinical characteristics of smoking (n 
39) and nonsmoking (n  46) patients with intermittent
claudication
Variable Nonsmokers Smokers P
Age (y) 71 (1) 70 (1) .27
Cigarette consumption (packs/d) 1.5 (0.2) 1.4 (0.1) .31
Duration of smoking (y) 34 (2) 45 (2) .01
Pack-years of smoking 51 (7) 63 (4) .02
Years since quitting smoking 14 (2) — —
Duration of IC (y) 4.8 (1.0) 4.6 (0.8) .87
Walking distance to IC (blocks) 2.7 (0.5) 1.8 (0.4) .15
Sex (% male) 89 87 .57
Race (% Caucasian) 61 44 .11
Diabetes (%) 39 26 .26
Hypertension (%) 59 74 .35
Hyperlipidemia (%) 59 54 .48
COPD (%) 7 10 .86
Dyspnea (%) 39 38 .93
Values are means (SEM) and percentages.
COPD, Chronic obstructive pulmonary disease; IC, intermittent claudica-
tion.
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following exercise rehabilitation between the groups, we
pooled the smokers and nonsmokers to assess whether the
change in claudication distances following exercise rehabil-
itation was related to the change in perfusion of the lower
extremity. The change in ICD was correlated with the
change in the ischemic window (r0.29, P .05), and
with the change in calf blood flow under reactive hyperemic
(r 0.39, P .001), and maximal hyperemic (r 0.44, P
 .001) conditions. Similarly, the change in ACD was
correlated with the change in the ischemic window (r 
0.33, P  .05), and with the change in calf blood flow
under reactive hyperemic (r  0.41, P  .001), and maxi-
mal hyperemic (r  0.44, P  .001) conditions. Similar
results were found when these analyses were performed
within each group.
The health-related quality of life measures shown in
Table V indicate that the smoking group had significantly
lower (P  .05) scores on bodily pain, general health,
mental health, and vitality than the nonsmoking group at
baseline, whereas the remaining variables were similar (P
Table III. Ambulatory function and physical activity level in smoking (n  39) and nonsmoking (n  46) patients with
intermittent claudication
Variable Pretest Posttest Change score
6-Minute walk pain-free distance (meters)
Nonsmokers 178 (13)* 222 (15)† 44 (17)†
Smokers 142 (14) 195 (21)† 53 (19)†
6-Minute walk distance (meters)
Nonsmokers 384 (12)* 411 (14)† 27 (9)†
Smokers 350 (12) 388 (16)† 38 (13)†
WIQ distance score (%)
Nonsmokers 43 (5)* 56 (6)† 13 (6)†
Smokers 27 (5) 42 (6)† 15 (6)†
WIQ speed score (%)
Nonsmokers 39 (4)* 43 (4) 4 (5)
Smokers 29 (4) 41 (5)† 12 (4)*†
WIQ stair climbing score (%)
Nonsmokers 56 (5)* 55 (6) 1 (5)
Smokers 39 (4) 57 (6)† 18 (5)*†
Daily physical activity (kcal/d)
Nonsmokers 388 (42)* 471 (51)† 83 (36)†
Smokers 271 (26) 372 (35)† 101 (30)†
Values are means (SEM).
WIQ, Walking impairment questionnaire.
*Significant difference between groups (P  .05).
†Significant change from the pretest (P  .05).
Table II. Treadmill measurements in smoking (n  39) and nonsmoking (n  46) patients with intermittent
claudication
Variable Pretest Posttest Change score
Initial claudication distance (meters)
Nonsmokers 199 (21)* 393 (41)† 194 (35)†
Smokers 160 (16) 351 (39)† 191 (29)†
Absolute claudication distance (meters)
Nonsmokers 430 (31)* 684 (49)† 254 (37)†
Smokers 365 (32) 665 (51)† 300 (38)†
Time to relief of claudication pain (min:s)
Nonsmokers 5:54 (0:37) 5:11 (0:46) 0:43 (0:35)
Smokers 6:53 (0:40) 6:11 (0:35) 0:42 (0:35)
Peak oxygen uptake (mL/kg1/min1)
Nonsmokers 14.2 (0.5)* 15.4 (0.4)† 1.2 (0.8)†
Smokers 13.0 (0.5) 15.0 (0.6)† 2.0 (0.5)†
Walking economy (mL/kg1/min1)
Nonsmokers 11.9 (0.4) 10.6 (0.4)† 1.3 (0.3)†
Smokers 11.4 (0.3) 10.4 (0.3)† 1.0 (0.3)†
Values are means (SEM).
mL/kg1/min1, Milliliters of oxygen per kilogram of body weight per minute.
*Significant difference between groups (P  .05).
†Significant change from the Pretest (P  .05).
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.05). Both groups had a significant (P  .05) and similar
improvement in physical function and bodily pain follow-
ing exercise rehabilitation. None of the other health domains
changed (P  .05) following exercise in either group.
DISCUSSION
The major findings of this investigation were (1) smok-
ers had greater impairments in claudication pain distances,
ambulatory function, physical activity, peripheral circula-
tion, and health-related quality of life than nonsmokers at
baseline and (2) both groups had similar improvements in
these measures following a 6-month exercise rehabilitation
program.
Baseline comparisons between smokers and non-
smokers. As expected, the smokers had a 24% greater
pack-year history of smoking at baseline than the nonsmok-
ers, because of 11 more years of smoking. However, the
two groups were similar on other clinical characteristics
such as age, claudication history, cardiovascular risk factors,
comorbid conditions, proportion of men and women, and
proportion of Caucasians and African Americans. Conse-
quently, baseline differences in claudication distances, am-
bulatory function, physical activity level, peripheral circula-
tion, and health-related quality of life can be attributed to
the greater exposure of cigarette smoking rather than to a
more complicated medical history.
The smokers were more limited by intermittent claudi-
cation than were the nonsmokers, as their ICD and ACD
were shorter by 39 meters (20%) and by 65 meters (15%),
respectively. This finding supports previous observations of
a 17% shorter ICD and a 20% shorter ACD in current
smokers compared with former smokers,19 and a 38%
shorter ICD and a 35% shorter ACD in current smokers
compared with patients with PAD who had never
smoked.39 Not surprisingly, the more rapid development
of claudication pain in the smokers resulted in an 8% lower
peak oxygen uptake than the smokers, supporting previous
findings of a 7% lower peak oxygen uptake in current
smokers compared with former smokers,19 and a 15% lower
peak oxygen uptake in current smokers compared with
Table IV. Peripheral hemodynamic measurements in smoking (n  39) and nonsmoking (n  46) patients with
intermittent claudication
Variable Pretest Posttest Change score
Calf blood flow: rest (mL/100 mL1/min1)
Nonsmokers 3.61 (0.15)* 3.96 (0.17)*† 0.35 (0.15)†
Smokers 2.84 (0.17) 3.17 (0.16)† 0.33 (0.17)†
Calf blood flow: PORH (mL/100 mL1/min1)
Nonsmokers 9.33 (0.56)* 12.09 (0.62)*† 2.76 (0.61)†
Smokers 7.90 (0.59) 9.55 (0.48)† 1.65 (0.60)†
Calf blood flow: maximal (mL/100 mL1/min1)
Nonsmokers 13.48 (0.71)* 17.11 (1.13)*† 3.63 (0.83)†
Smokers 10.58 (0.74) 13.26 (0.96)† 2.68 (0.67)†
Ankle brachial index: rest
Nonsmokers 0.67 (0.03) 0.68 (0.03) 0.01 (0.02)
Smokers 0.60 (0.03) 0.59 (0.03) 0.01 (0.01)
Ischemic window (AUC)
Nonsmokers 251 (32) 177 (25)† 74 (28)†
Smokers 239 (18) 154 (17)† 85 (19)†
Values are means (SEM).
PORH, Postocclusive reactive hyperemia; AUC, area under the curve; mL/100 mL1/min1, milliliters of blood flow per 100 mL of tissue per minute.
*Significant difference between groups (P  .05).
†Significant change from the pretest (P  .05).
Table V. Health-related quality of life in smoking (n 
39) and nonsmoking (n  46) patients with intermittent
claudication
Variable Pretest Posttest Change score
Physical function
Nonsmokers 51 (5) 61 (4)† 10 (3)†
Smokers 48 (6) 59 (6)† 11 (2)†
Role limitations: physical
Nonsmokers 71 (8) 69 (8) –2 (5)
Smokers 66 (11) 72 (13) 6 (7)
Bodily pain
Nonsmokers 60 (4)* 69 (5)† 9 (3)†
Smokers 49 (5) 62 (7)† 13 (4)†
General health
Nonsmokers 62 (3)* 62 (4)* 0 (3)
Smokers 48 (5) 45 (6) –3 (4)
Social function
Nonsmokers 87 (5) 88 (4) 1 (2)
Smokers 75 (7) 82 (6) 7 (3)
Role limitations: emotional
Nonsmokers 75 (8) 78 (8) 3 (6)
Smokers 67 (7) 72 (9) 5 (10)
Mental health
Nonsmokers 81 (3)* 83 (3)* 2 (3)
Smokers 73 (4) 73 (4) 0 (2)
Vitality
Nonsmokers 64 (3)* 66 (4)* 2 (3)
Smokers 53 (5) 50 (5) 3 (3)
Values are means (SEM).
*Significant difference between groups (P  .05).
†Significant change from the pretest (P  .05).
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patients with PAD who had never smoked.39 The impaired
treadmill performance of the smokers translated into worse
ambulatory function during the 6-minute walk test, as the
pain-free distance and total walking distance were 20% and
9% lower than the nonsmokers, respectively. The negative
effect of cigarette smoking on 6-minute walk performance
in patients with PAD has been documented in previous
work from our laboratory,39-41 suggesting that current
smoking places further limitations on an over ground walk-
ing task that closely resembles community-based walking.
This point is underscored by noting that the smokers had a
worse perception in their ability to walk various distances
and speeds and to climb stairs than their nonsmoking
counterparts, possibly contributing to their lower daily
physical activity in the community setting. Previous work
from our laboratory supports the detrimental influence of
cigarette smoking on both perceived ambulatory func-
tion39-41 and on daily physical activity.20,39-41 Interest-
ingly, the lower baseline functional status of the smokers
negatively affected their quality of life in both physical and
mental health domains compared with the nonsmoking
patients with PAD.
The smokers had a lower calf blood flow than the
nonsmokers under resting, reactive hyperemic, and maxi-
mal hyperemic conditions despite having similar severity of
PAD as measured by ABI and ischemic window values. This
finding supports previous studies20,39,41 and suggests that
cigarette smoking results in peripheral vasoconstriction in
the lower extremities.17 Furthermore, the greater impair-
ment in perfusion of the calf musculature in the smokers at
baseline is a potential explanation for their lower claudica-
tion distances and overall physical function than in the
nonsmoking patients.20,41
Responses to exercise rehabilitation in smokers and
nonsmokers. Adherence to the exercise rehabilitation
program was similar between the smokers and nonsmokers,
as both groups attended approximately 75% of the possible
exercise training sessions. This finding is similar to the
exercise attendance reported in a previous randomized,
controlled exercise trial from our laboratory8 as well as from
other investigations42,43 and is considerably better than the
45% attendance rate reported during a 6-month exercise
program in another report.44 Our data indicate that pa-
tients with PAD who currently smoke adhere to a program
of exercise just as well as their nonsmoking counterparts.
Furthermore, a similar percentage of smokers (22%) and
nonsmokers (18%) dropped out in the early phase of our
exercise program, and none of the patients experienced
serious adverse events that caused them to discontinue
from the exercise program. The attrition rate of patients
enrolled in this study is similar to that found in previous
reports having a study duration between 3 and 6
months7,8,45 and is considerably smaller than the 40%
attrition rate that we found in a long-term exercise study
lasting 18 months.9 Collectively, data from this study indi-
cate that patients with PAD who currently smoke are
equally likely to attend and safely complete a supervised
program of exercise as are their nonsmoking counterparts.
The nonsmoking patients with PAD increased their
ICD by 194 meters (97%) and their ACD by 254 meters
(59%) after 6 months of exercise rehabilitation, supporting
previous reports from our laboratory.6-9 The smoking
group demonstrated similar gains in ICD (191 meters;
119%) and in ACD (300 meters; 82%) after exercise reha-
bilitation, suggesting that concomitant cigarette smoking
does not interfere with exercise-mediated improvements in
claudication walking distances. This notion supports a pre-
vious investigation that found no significant correlation
between the smoking habits at baseline and the 78% in-
crease in ICD and the 61% increase in ACD in 51 patients
with PAD who completed 6 months of exercise
rehabilitation.43
In addition to the improvements in ICD and ACD after
exercise rehabilitation, the nonsmoking and smoking
groups demonstrated similar exercise-mediated increases in
peak oxygen uptake of 8% and 15%, respectively, as well as
similar improvements in walking economy of 11% and 9%.
The increase in peak oxygen uptake is supported by
some7,9-13 but not all investigations.8,46 The improvement
in walking economy following a program of exercise reha-
bilitation, demonstrated by a reduced oxygen uptake to
accomplish a given exercise task, supports previous investi-
gations7-11,26 The combined improvements in peak oxygen
uptake and walking economy indicate that both the non-
smoking and smoking groups were able to perform the
submaximal walking test at only 69% of their peak oxygen
uptake following exercise rehabilitation, compared with
84% and 88% at baseline, respectively. This is the first
investigation to compare the changes in peak oxygen up-
take and walking economy in smokers and nonsmokers
following exercise rehabilitation, and the data suggest that
patients with PAD who currently smoke can improve their
cardiopulmonary function and their efficiency in walking to
a similar extent as their nonsmoking counterparts.
The lower relative intensity of treadmill walking follow-
ing exercise rehabilitation could have important implica-
tions in performing tasks that more closely approximate
activities of daily living in the community setting. For
example, both the smoking and nonsmoking patients ex-
perienced significant and similar improvements in the pain-
free walking distance and the total walking distance during
the 6-minute walk test and in monitored daily physical
activity in the community setting. These findings support
previous investigations7-9 and suggest that current smok-
ing status has no effect on the improvements in ambulatory
function and physical activity level following a program of
exercise rehabilitation. From a clinical standpoint, these
gains may be more meaningful for the smokers because
their extreme sedentary lifestyle and greater ambulatory
impairment at baseline places them at a higher risk of
subsequent morbidity and mortality.47,48 The greater rela-
tive gains in ambulation and physical activity of the smokers
translated into greater gains in their perceived ability to
ambulate at various speeds and to climb stairs compared
with their nonsmoking counterparts. The overall improve-
ment in claudication pain and physical function following
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exercise rehabilitation resulted in similar gains in health-
related measures of quality of life between the smokers and
the nonsmokers. It is particularly interesting to note that a
program of exercise rehabilitation improved specific do-
mains in both physical health and mental health in patients
with PAD with intermittent claudication regardless of
smoking status. The exercise-mediated increase in the phys-
ical function domain is supported by previous investiga-
tions,12,13,49,50 as is the increase in bodily pain.49 How-
ever, this is the first study to report improvements in mental
health and vitality following exercise rehabilitation.
Both the smoking and nonsmoking patients had signif-
icant and similar increases in perfusion of the calf muscula-
ture following exercise rehabilitation, suggesting that en-
hanced peripheral circulation is a potential mechanism for
the improvement in claudication pain distances and ambu-
latory function. Exercise-mediated increases in peripheral
circulation, as measured by venous occlusion plethysmog-
raphy, are supported by some7-10 but not in all studies.46,51
The decrease in the ischemic window in both groups fol-
lowing exercise rehabilitation lends further evidence of
enhanced perfusion of the lower extremities and is sup-
ported by previous investigations.7,32 Collectively, these
findings suggest that lower-extremity perfusion increases
after a program of exercise rehabilitation in patients with
PAD with intermittent claudication and that smokers ex-
perience the same hemodynamic improvements as their
nonsmoking counterparts. The enhanced peripheral circu-
lation may be due to improvements in nitric oxide–medi-
ated endothelial function seen in patients with PAD after a
program of exercise rehabilitation.52
Although the results of this trial support the efficacy of
exercise rehabilitation for patients with PAD regardless of
their smoking status, several limitations exist. First, patients
who participated in this trial were volunteers and, therefore,
may represent those patients who were more interested in
exercise, who had better access to transportation to the
program, and who were in relatively better health than
patients with PAD who did not volunteer. Second, the
study participants were predominantly men. Consequently,
the efficacy of exercise for both smokers and nonsmokers
may not generalize to women limited by intermittent clau-
dication. Finally, some bias in the study results could exist
because the analyses were limited to only those patients
who completed the study. Although there were no differ-
ences in baseline characteristics between the 85 patients
who completed the trial and the 21 patients who withdrew
(data not shown), the possibility that those patients who
withdrew from the study would have responded less favor-
ably to exercise cannot be ruled out.
SUMMARY AND CONCLUSIONS
In summary, the major findings of this investigation
were (1) smokers had greater impairments in claudication
pain distances, ambulatory function, physical activity, pe-
ripheral circulation, and health-related quality of life than
did nonsmokers at baseline and (2) both groups had similar
improvements in these measures following a 6-month ex-
ercise rehabilitation program. In conclusion, exercise reha-
bilitation is an effective therapy to improve functional in-
dependence in both smoking and nonsmoking patients
with PAD limited by intermittent claudication. Smokers
with intermittent claudication are prime candidates for
exercise rehabilitation because their relatively low baseline
physical function does not impair their ability to regain lost
functional independence to levels similar to nonsmoking
patients with PAD.
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